Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Gastroenterology

Taming the Acid: Medical Management of ZES

At a Glance

Zollinger-Ellison syndrome usually requires an individualized, often high-dose acid-blocking medicine called a PPI to control excess stomach acid and prevent ulcers, bleeding, and perforation. Patients should not stop or change treatment without a clinician’s plan and need long-term monitoring.

In Zollinger-Ellison Syndrome (ZES), the most immediate and lifelong priority is controlling the excess gastric acid to prevent severe ulcers and bleeding [1][2]. While surgery may be considered for the tumor, medical management of the acid is essential.

The Standard of Care: Proton Pump Inhibitors (PPIs)

Proton Pump Inhibitors (PPIs)—such as omeprazole, pantoprazole, lansoprazole, and esomeprazole—are the cornerstone of ZES treatment [3]. They work by turning off the tiny “pumps” in your stomach lining that produce acid.

In ZES, the doses required are higher than those used for typical acid reflux. Your specialist will prescribe a specific PPI regimen tailored to your needs. Do not compare your dose to standard over-the-counter instructions, and never self-titrate your dose [3][4].

Titrating Your Dose

There is no “one-size-fits-all” dose for ZES. Your doctor will carefully adjust (titrate) your medication based on how your body responds [3][5].

To ensure the dose is correct, doctors look for:

  1. Symptom Control: Disappearance of abdominal pain, heartburn, and watery diarrhea [5].
  2. Acid Measurement: In some cases, doctors measure your Basal Acid Output (BAO) to ensure acid production is adequately suppressed [5].

If you still have symptoms or if an endoscopy shows your ulcers haven’t healed, your doctor will likely increase your dose or frequency [6][5]. Delayed-release PPIs are often most effective when taken 30 to 60 minutes before meals.

Medication Management and Safety Rules

The most important safety rule in ZES management is this: Never stop or change your PPI abruptly without a medical plan.

Because your tumors continuously signal your stomach to produce acid, the PPI is essential. If you stop your medication, symptoms can recur, potentially leading to rapid development of severe ulcers, gastrointestinal perforation, or internal bleeding [7][4][3].

Practical Medication Guidance:

  • Missed or Vomited Doses: Ask your doctor what to do if you miss a dose. Generally, do not double the next dose on your own. If you are vomiting and cannot keep the medication down, contact your care team or seek emergency care immediately. You may need an intravenous (IV) PPI “bridge” [8].
  • Procedures and Fasting: Routine fasting for procedures (like being “NPO” before surgery) does not automatically mean you must stop your PPI. Always inform anesthesiologists and surgeons that you have ZES and must maintain acid suppression.
  • Travel and Refills: Always carry your medication list and keep extra PPI supplies when traveling.

Long-Term Monitoring and Side Effects

Because ZES often requires high-dose PPI therapy for years or a lifetime, your care team will monitor you for potential side effects. Monitoring is individualized based on your dose, duration, diet, and overall health.

  • Vitamin B12 and Minerals: Long-term PPIs can interfere with how your body absorbs Vitamin B12, magnesium, and iron from food [9][10][11]. Your doctor will periodically check these levels. Low magnesium (hypomagnesemia) can cause muscle cramps or heart rhythm issues.
  • Bone Health: Some studies suggest that long-term PPI use may slightly increase the risk of bone fractures [12].
  • Kidney Health: Your doctor will use routine blood tests (like creatinine) to monitor kidney function. In rare cases, PPIs can cause acute interstitial nephritis (kidney inflammation) [10].
  • Drug Interactions: PPIs can affect how other medicines are absorbed. Always review all over-the-counter medicines and supplements with your pharmacist.

Despite these risks, for someone with ZES, the benefits of preventing a perforated ulcer far outweigh the potential side effects of the medication [4]. Managing ZES is about finding the lowest effective dose that keeps you safe and symptom-free [3].

Common questions in this guide

Why are high-dose PPIs needed for Zollinger-Ellison syndrome?
Tumors in ZES continuously signal the stomach to produce too much acid. Higher PPI doses than those used for ordinary reflux may be needed to control symptoms and prevent ulcers, bleeding, or perforation.
How does my doctor decide the right PPI dose for ZES?
The dose is individualized based on whether abdominal pain, heartburn, and watery diarrhea are controlled and whether ulcers have healed on endoscopy. In some cases, the clinician also measures basal acid output, a test of how much acid the stomach makes.
When should I take my PPI for ZES?
Delayed-release PPIs are often most effective when taken 30 to 60 minutes before meals, but your prescribed schedule may differ, especially if you take more than one dose daily. Do not change the dose or timing without asking your care team.
What should I do if I miss or vomit a ZES medication dose?
Do not double the next dose unless your clinician specifically tells you to. If you vomit and cannot keep the PPI down, contact your care team or seek emergency medical care immediately; an intravenous PPI may be needed temporarily.
Should I stop my PPI before a procedure or while fasting?
Routine fasting does not automatically mean you should stop acid-suppressing treatment. Tell the anesthesiologist and surgeon that you have ZES, and agree on a plan to maintain acid suppression before the procedure.
What monitoring is needed during long-term PPI treatment for ZES?
Your clinician may check magnesium, vitamin B12, iron, and kidney function with blood tests and consider your bone health and other medicines. The schedule depends on your dose, length of treatment, diet, and overall health.
Can nighttime heartburn or diarrhea mean my ZES PPI dose needs adjustment?
Yes, breakthrough heartburn, abdominal pain, or watery diarrhea can suggest that acid suppression needs review, especially if symptoms return after a missed dose. Tell your care team rather than increasing the medicine yourself.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my specific target for adequate acid suppression—is it based solely on my symptoms, or will we do a gastric acid output test?
  2. 2.Because of my PPI dose, how often should we check my magnesium, vitamin B12, and kidney function?
  3. 3.Is it best for me to take my PPI twice a day rather than all at once, and should I take it before meals?
  4. 4.If I ever need a procedure that requires fasting or stopping my medication, what is our emergency plan to prevent acid recurrence?
  5. 5.Are there any specific medications or supplements (like iron or calcium) that might not be absorbed well because of my PPI therapy?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    The Zollinger-Ellison syndrome: is there a role for somatostatin analogues in the treatment of the gastrinoma?

    Guarnotta V, Martini C, Davì MV, et al.

    Endocrine 2018; (60(1)):15-27 doi:10.1007/s12020-017-1420-4.

    PMID: 29019150
  2. 2

    Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.

    Lee L, Ramos-Alvarez I, Ito T, Jensen RT

    International journal of molecular sciences 2019; (20(20)) doi:10.3390/ijms20205128.

    PMID: 31623145
  3. 3

    Successful Lifetime/Long-Term Medical Treatment of Acid Hypersecretion in Zollinger-Ellison Syndrome (ZES): Myth or Fact? Insights from an Analysis of Results of NIH Long-Term Prospective Studies of ZES.

    Ito T, Ramos-Alvarez I, Jensen RT

    Cancers 2023; (15(5)) doi:10.3390/cancers15051377.

    PMID: 36900170
  4. 4

    Total gastrectomy for severe proton pump inhibitor-induced hypomagnesemia in a MEN1/Zollinger Ellison syndrome patient.

    Perrier M, Delemer B, Deguelte S, et al.

    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2021; (21(1)):236-239 doi:10.1016/j.pan.2020.12.002.

    PMID: 33309626
  5. 5

    Gastrointestinal surveillance in patients with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome.

    Schueler SA, Sharma SLT, Kamal N, et al.

    Scandinavian journal of gastroenterology 2025; (60(10)):966-971 doi:10.1080/00365521.2025.2541209.

    PMID: 40847773
  6. 6

    Diagnostic and Treatment Approaches for Refractory Peptic Ulcers.

    Kim HU

    Clinical endoscopy 2015; (48(4)):285-90 doi:10.5946/ce.2015.48.4.285.

    PMID: 26240800
  7. 7

    Assessing for Multiple Endocrine Neoplasia Type 1 in Patients Evaluated for Zollinger-Ellison Syndrome-Clues to a Safer Diagnostic Process.

    Singh Ospina N, Donegan D, Rodriguez-Gutierrez R, et al.

    The American journal of medicine 2017; (130(5)):603-605 doi:10.1016/j.amjmed.2016.11.035.

    PMID: 28011308
  8. 8

    Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies.

    Rossi RE, Elvevi A, Citterio D, et al.

    World journal of gastroenterology 2021; (27(35)):5890-5907 doi:10.3748/wjg.v27.i35.5890.

    PMID: 34629807
  9. 9

    Long-Term Proton Pump Inhibitor-Acid Suppressive Treatment Can Cause Vitamin B12 Deficiency in Zollinger-Ellison Syndrome (ZES) Patients.

    Ito T, Ramos-Alvarez I, Jensen RT

    International journal of molecular sciences 2024; (25(13)) doi:10.3390/ijms25137286.

    PMID: 39000391
  10. 10

    Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors.

    Maideen NMP

    Chonnam medical journal 2023; (59(2)):115-127 doi:10.4068/cmj.2023.59.2.115.

    PMID: 37303818
  11. 11

    Proton pump inhibitor-induced hypomagnesemia complicated with serious cardiac arrhythmias.

    Chrysant SG

    Expert review of cardiovascular therapy 2019; (17(5)):345-351 doi:10.1080/14779072.2019.1615446.

    PMID: 31092056
  12. 12

    Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies.

    Poly TN, Islam MM, Yang HC, et al.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2019; (30(1)):103-114 doi:10.1007/s00198-018-4788-y.

    PMID: 30539272

This page is for informational purposes only and does not constitute medical advice. Your specialist should guide PPI dosing, monitoring, and plans for missed doses or procedures.

Get notified when new evidence is published on Zollinger-Ellison syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.